Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma
- Author
- UNTERHALT, M1 ; HERRMANN, R; FREUND, M; KREUSER, E.-D; DIETZFELBINGER, H; BODENSTEIN, H; ENGERT, A; STAUDER, R; EIMERMACHER, H; LANDYS, K; HIDDEMANN, W; TIEMANN, M; PARWARESCH, R; STEIN, H; TRÜMPER, L; NAHLER, M; REUSS-BORST, M; TIRIER, C; NEUBAUER, A
[1] Dept of Hematology and Oncology, University of Göttingen, Germany
German Low-Grade Lymphoma Study Group, Germany - Source
Leukemia. 1996, Vol 10, Num 5, pp 836-843 ; ref : 28 ref
- CODEN
- LEUKED
- ISSN
- 0887-6924
- Scientific domain
- Medical oncology; Hematology
- Publisher
- Nature Publishing, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Agent alkylant Anticancéreux Antimitotique Antimétabolite Chimiothérapie Cyclophosphamide Etude comparative Homme Lymphome non hodgkinien Mitoxantrone Polychimiothérapie Prednimustine Prednisone Protocole thérapeutique Stade avancé Traitement Vincristine Faible malignité Protocole COP Protocole PmM Alcaloïde Corticostéroïde Glucocorticoïde Hémopathie maligne Lymphoprolifératif syndrome
- Keyword (en)
- Alkylating agent Antineoplastic agent Antimitotic Antimetabolic Chemotherapy Comparative study Human Non Hodgkin lymphoma Polychemotherapy Prednisone Therapeutic protocol Advanced stage Treatment Low malignancy Alkaloid Corticosteroid Glucocorticoid Malignant hemopathy Lymphoproliferative syndrome
- Keyword (es)
- Agente alquilante Anticanceroso Antimitótico Antimetabólito Quimioterapia Estudio comparativo Hombre Linfoma no Hodgkin Poliquimioterapia Prednisona Protocolo terapéutico Estadio avanzado Tratamiento Alcaloide Corticoesteroide Glucocorticoide Hemopatía maligna Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3091618
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"10\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"836\";s:8:\"\u0000*\u0000epage\";s:3:\"843\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"UNTERHALT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:11:\"HERRMANN, R\";i:1;s:9:\"FREUND, M\";i:2;s:13:\"KREUSER, E.-D\";i:3;s:17:\"DIETZFELBINGER, H\";i:4;s:13:\"BODENSTEIN, H\";i:5;s:9:\"ENGERT, A\";i:6;s:10:\"STAUDER, R\";i:7;s:14:\"EIMERMACHER, H\";i:8;s:9:\"LANDYS, K\";i:9;s:12:\"HIDDEMANN, W\";i:10;s:10:\"TIEMANN, M\";i:11;s:13:\"PARWARESCH, R\";i:12;s:8:\"STEIN, H\";i:13;s:11:\"TR\u00dcMPER, L\";i:14;s:9:\"NAHLER, M\";i:15;s:14:\"REUSS-BORST, M\";i:16;s:9:\"TIRIER, C\";i:17;s:11:\"NEUBAUER, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"10\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"836\";s:8:\"\u0000*\u0000epage\";s:3:\"843\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"UNTERHALT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:11:\"HERRMANN, R\";i:1;s:9:\"FREUND, M\";i:2;s:13:\"KREUSER, E.-D\";i:3;s:17:\"DIETZFELBINGER, H\";i:4;s:13:\"BODENSTEIN, H\";i:5;s:9:\"ENGERT, A\";i:6;s:10:\"STAUDER, R\";i:7;s:14:\"EIMERMACHER, H\";i:8;s:9:\"LANDYS, K\";i:9;s:12:\"HIDDEMANN, W\";i:10;s:10:\"TIEMANN, M\";i:11;s:13:\"PARWARESCH, R\";i:12;s:8:\"STEIN, H\";i:13;s:11:\"TR\u00dcMPER, L\";i:14;s:9:\"NAHLER, M\";i:15;s:14:\"REUSS-BORST, M\";i:16;s:9:\"TIRIER, C\";i:17;s:11:\"NEUBAUER, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"10\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"836\";s:8:\"\u0000*\u0000epage\";s:3:\"843\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"UNTERHALT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:11:\"HERRMANN, R\";i:1;s:9:\"FREUND, M\";i:2;s:13:\"KREUSER, E.-D\";i:3;s:17:\"DIETZFELBINGER, H\";i:4;s:13:\"BODENSTEIN, H\";i:5;s:9:\"ENGERT, A\";i:6;s:10:\"STAUDER, R\";i:7;s:14:\"EIMERMACHER, H\";i:8;s:9:\"LANDYS, K\";i:9;s:12:\"HIDDEMANN, W\";i:10;s:10:\"TIEMANN, M\";i:11;s:13:\"PARWARESCH, R\";i:12;s:8:\"STEIN, H\";i:13;s:11:\"TR\u00dcMPER, L\";i:14;s:9:\"NAHLER, M\";i:15;s:14:\"REUSS-BORST, M\";i:16;s:9:\"TIRIER, C\";i:17;s:11:\"NEUBAUER, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"10\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"836\";s:8:\"\u0000*\u0000epage\";s:3:\"843\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"UNTERHALT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:11:\"HERRMANN, R\";i:1;s:9:\"FREUND, M\";i:2;s:13:\"KREUSER, E.-D\";i:3;s:17:\"DIETZFELBINGER, H\";i:4;s:13:\"BODENSTEIN, H\";i:5;s:9:\"ENGERT, A\";i:6;s:10:\"STAUDER, R\";i:7;s:14:\"EIMERMACHER, H\";i:8;s:9:\"LANDYS, K\";i:9;s:12:\"HIDDEMANN, W\";i:10;s:10:\"TIEMANN, M\";i:11;s:13:\"PARWARESCH, R\";i:12;s:8:\"STEIN, H\";i:13;s:11:\"TR\u00dcMPER, L\";i:14;s:9:\"NAHLER, M\";i:15;s:14:\"REUSS-BORST, M\";i:16;s:9:\"TIRIER, C\";i:17;s:11:\"NEUBAUER, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"10\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"836\";s:8:\"\u0000*\u0000epage\";s:3:\"843\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"UNTERHALT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:11:\"HERRMANN, R\";i:1;s:9:\"FREUND, M\";i:2;s:13:\"KREUSER, E.-D\";i:3;s:17:\"DIETZFELBINGER, H\";i:4;s:13:\"BODENSTEIN, H\";i:5;s:9:\"ENGERT, A\";i:6;s:10:\"STAUDER, R\";i:7;s:14:\"EIMERMACHER, H\";i:8;s:9:\"LANDYS, K\";i:9;s:12:\"HIDDEMANN, W\";i:10;s:10:\"TIEMANN, M\";i:11;s:13:\"PARWARESCH, R\";i:12;s:8:\"STEIN, H\";i:13;s:11:\"TR\u00dcMPER, L\";i:14;s:9:\"NAHLER, M\";i:15;s:14:\"REUSS-BORST, M\";i:16;s:9:\"TIRIER, C\";i:17;s:11:\"NEUBAUER, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Predimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
